2
3
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T79207 | SUCNR1-IN-1 | ||
SUCNR1-IN-1 (Compound 20) serves as a potent SUCNR1 inhibitor, exhibiting an IC50 of 88 nM against hSUCNR1. It is utilized in the study of rheumatoid arthritis, liver fibrosis, and obesity [1]. | |||
T81075 | SUCNR1-IN-2 | ||
SUCNR1-IN-2 (Statement 35) serves as an inhibitor of both succinate and succinate receptor 1, utilized in research pertaining to neurodegenerative disorders, including neuroinflammation [1]. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-03256 | CNR1 Protein, Rat, Recombinant (His) | Rat | E. coli |
CNR1 Protein, Rat, Recombinant (His) is expressed in E. coli expression system with N-10xHis tag. The predicted molecular weight is 58.9 kDa and the accession number is P20272. | |||
TMPH-01035 | CNR1 Protein-VLP, Human, Recombinant (His) | Human | HEK293 Cells |
CNR1 Protein-VLP, Human, Recombinant (His) is expressed in HEK293 mammalian cells with C-10xHis tag. The predicted molecular weight is 54.6 kDa and the accession number is P21554. | |||
TMPY-06623 | CB2/CNR2 Protein, Human, Recombinant | Human | HEK293 Cells |
Genetic variants within the CNR2 gene encoding the cannabinoid receptor CB2 are associated with osteoporosis and low bone mineral density (BMD) in case-control studies. There is a possibility that genetic variants of the... |